Reference
Ho S, et al. Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naive HIV-1 infected adults. AIDS Research and Therapy 17: 23, No. 1, 21 May 2020. Available from: URL: http://doi.org/10.1186/s12981-020-00272-5
Rights and permissions
About this article
Cite this article
Antiretrovirals. Reactions Weekly 1813, 43 (2020). https://doi.org/10.1007/s40278-020-80800-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-80800-5